JS

Jomy S.

Director, Real World Evidence at Sio Gene Therapies

Jomy S. has a diverse work experience spanning various roles and industries. In 2014, Jomy served as the Manager of a Science Lab at Chamberlain School of Nursing/DeVry University, where they established and expanded the science laboratory. They also acted as a liaison between subsidiary organizations and cross-functional teams. From 2016 to 2019, Jomy worked as a Part-time Faculty at Kennesaw State University.

In 2008, Jomy was employed as a Sr. Project Coordinator of Research at Emory University. During this time, they worked on research projects.

Starting in 2019, Jomy worked for IQVIA/Q² Solutions as a Global Project Manager for Clinical Trials. They managed multiple global early engagement and proof of concept clinical trials. Jomy also served as a Bio-sample Operations Lead, providing strategic leadership and project management with a focus on tracking bio samples. They were also a Manager in the Life Science Strategy in the Applied Real World Solutions division at IQVIA.

Currently, Jomy works at Sio Gene Therapies as a Real World Evidence professional. The specific details of this role are not provided.

Jomy S. has a strong educational background in the field of Chemistry. Jomy received their Doctor of Philosophy (PhD) degree in Chemistry from The University of British Columbia. Prior to their PhD, they continued their academic pursuits at the University of California, Berkeley, where they served as a Howard Hughes Post-doctoral Fellow in Chemical Biology. In addition to their degrees, Jomy has obtained two additional certifications. In December 2018, they earned the Project Management Professional (PMP) certification from the Project Management Institute. Furthermore, in December 2020, they obtained the Lean Six Sigma Green Belt Certification from The Council for Six Sigma Certification (CSSC).

Links

Previous companies

Emory University logo
IQVIA logo
Kennesaw State University logo

Org chart

Timeline

  • Director, Real World Evidence

    October, 2021 - present

View in org chart